Drozitumab - CISMeF

Preferred Label : Drozitumab;

NCIt synonyms : Anti-DR5 Monoclonal Antibody; Immunoglobulin G1, anti-(human tumor necrosis factor receptor superfamily member 10B (death receptor 5, TRAIL-R2, CD262 antigen)); [113-lysine,116-threonine,360-glutamic acid,362-methionine]human monoclonal gamma-1 heavy chain (224-212')-disulfide with human monoclonal lambda-3 light chain (230-230'':233-233'')-bisdisulfide dimer; rhuMAb DR5;

UNII : SQ67484MA7;

CAS number : 912628-39-8;

Molecule name : PRO95780;

Details

Origin ID

C95784;

UMLS CUI

C2987421;

Automatic exact mappings (from CISMeF team)
- rhumab DR5 [MeSH concept]
Currated CISMeF NLP mapping
- drozitumab [MeSH concept]
- drozitumab [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- drozitumab [MeSH Supplementary Concept]
- drozitumab [MeSH concept]
chemical_or_drug_has_mechanism_of_action
- Antigen Binding [NCIt concept]
concept_is_in_subset
- CTRP Agent Terminology [NCIt concept]
- CTRP Terminology [NCIt concept]
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- GDC Terminology [NCIt concept]
- GDC Therapeutic Agent Terminology [NCIt concept]
- GDC Value Terminology [NCIt concept]
- NCIt Antineoplastic Agent Terminology [NCIt concept]
has_target
- Tumor Necrosis Factor Receptor Superfamily Member 10B [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients